Safety publicity "sweep"
Release time:
2020-07-22
Safety Publicity "Sweep"
This safety month, employees of the Environmental Safety Department of Daye Jianfeng Cement Company have developed a new skill-to carry out safety production publicity through two-dimensional codes. As long as the drivers sweep, safety knowledge will immediately "arrive", much more convenient than before.
Safety management is an important work of an enterprise, and the safety management of personnel in outsourced units with high mobility such as logistics and transportation has always been the focus and difficulty of safety management. In the past, for the safety publicity of this group, Daye Jianfeng Environmental Security Department was mainly "routine actions", pulling banners, posting slogans, issuing notices, etc., but it was limited by the actual situation of information dissemination and acquisition methods, and high mobility of personnel. The speed and coverage are not ideal. Especially in the work improvement plan of Daye peak this year, more stringent requirements have been put forward for logistics and transportation management. How to make drivers understand and abide by the relevant system requirements in time is obviously a new topic to be solved urgently.
After discussion, combined with the current widespread application of WeChat in work, there are driver WeChat groups for delivery, logistics information groups for procurement, and acceptance groups for site acceptance. The staff of the Environmental Security Department agreed that this is a very good safety knowledge publicity platform. As for the mode of transmission, the most convenient is, of course, "sweep" it.
As a result, the staff of the Environmental Security Department found their own information and made two illustrated publicity courseware, "Ten Prohibitions on Driver Safety and Civilization" and "Traffic Safety Knowledge Training", which were shared in WeChat group through two-dimensional codes. As soon as this new publicity method was "released", it was well received by drivers. Only two days after the "driver safety and civilization are not allowed" was launched, the scanning volume reached more than 200, and the vehicle order in the factory area has also improved a lot.
Now, in addition to sharing in various work WeChat groups, two-dimensional codes of safety knowledge will also be posted in places where there is a large flow of people, such as Daye Peak Delivery Room. Drivers can obtain the safety publicity content compiled by the Environmental Security Department by scanning it while waiting for the formalities. Moreover, through the management platform, the environmental safety department can also carry out statistical analysis on the scanning quantity and track and understand the learning situation. Not only that, the workshop team can also carry out corresponding safety publicity and training among employees through the two-dimensional code. In the next step, the Ministry of Environmental Security plans to further sort out the business process and safety publicity of the factory area, and compile the data to be released and updated in time through two-dimensional codes, so that everyone can obtain safety knowledge more conveniently and quickly, thus improving the safety management level of Daye Peak. (Wu Xinqiong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31